Hearing loss in children and young adults receiving cisplatin with or without prior cranial irradiation.

PubWeight™: 1.85‹?› | Rank: Top 3%

🔗 View Article (PMID 2715805)

Published in J Clin Oncol on June 01, 1989

Authors

M J Schell1, V A McHaney, A A Green, L E Kun, F A Hayes, M Horowitz, W H Meyer

Author Affiliations

1: Department of Biostatistics, St. Jude Children's Research Hospital, Memphis, TN 38101.

Articles citing this

The role of inherited TPMT and COMT genetic variation in cisplatin-induced ototoxicity in children with cancer. Clin Pharmacol Ther (2013) 2.40

Carboplatin-associated ototoxicity in children with retinoblastoma. J Clin Oncol (2012) 2.32

Yield of screening for long-term complications using the children's oncology group long-term follow-up guidelines. J Clin Oncol (2012) 1.26

Auditory late effects of childhood cancer therapy: a report from the Children's Oncology Group. Pediatrics (2010) 1.19

Auditory complications in childhood cancer survivors: a report from the childhood cancer survivor study. Pediatr Blood Cancer (2011) 0.98

Chemotherapy-induced peripheral neurotoxicity and ototoxicity: new paradigms for translational genomics. J Natl Cancer Inst (2014) 0.94

A phase II study of preradiotherapy chemotherapy followed by hyperfractionated radiotherapy for newly diagnosed high-risk medulloblastoma/primitive neuroectodermal tumor: a report from the Children's Oncology Group (CCG 9931). Int J Radiat Oncol Biol Phys (2009) 0.89

Co-administration of cisplatin and furosemide causes rapid and massive loss of cochlear hair cells in mice. Neurotox Res (2011) 0.88

Ototoxicity in children with high-risk neuroblastoma: prevalence, risk factors, and concordance of grading scales--a report from the Children's Oncology Group. J Clin Oncol (2014) 0.88

Role of genetic susceptibility in development of treatment-related adverse outcomes in cancer survivors. Cancer Epidemiol Biomarkers Prev (2011) 0.87

Proton radiotherapy for solid tumors of childhood. Technol Cancer Res Treat (2012) 0.85

Phase 1 study of an oxaliplatin and etoposide regimen in pediatric patients with recurrent solid tumors. Cancer (2009) 0.85

A review of clinical and histological features of Spanish paediatric medulloblastomas during the last 21 years. Childs Nerv Syst (2005) 0.82

Cisplatin and cranial irradiation-related hearing loss in children. Ochsner J (2012) 0.80

Comprehensive Audiometric Analysis of Hearing Impairment and Tinnitus After Cisplatin-Based Chemotherapy in Survivors of Adult-Onset Cancer. J Clin Oncol (2016) 0.79

Prospective evaluation of cisplatin- and carboplatin-mediated ototoxicity in paediatric and adult soft tissue and osteosarcoma patients. Oncol Lett (2012) 0.78

Necrosis after craniospinal irradiation: results from a prospective series of children with central nervous system embryonal tumors. Int J Radiat Oncol Biol Phys (2012) 0.78

Cost-effectiveness analysis of cochlear dose reduction by proton beam therapy for medulloblastoma in childhood. J Radiat Res (2013) 0.78

Heat shock protein-mediated protection against Cisplatin-induced hair cell death. J Assoc Res Otolaryngol (2014) 0.77

SOD2 genetic variant associated with treatment-related ototoxicity in cisplatin-treated pediatric medulloblastoma. Cancer Med (2015) 0.76

Ototoxicity evaluation in medulloblastoma patients treated with involved field boost using intensity-modulated radiation therapy (IMRT): a retrospective review. Radiat Oncol (2014) 0.76

TPMT, COMT and ACYP2 genetic variants in paediatric cancer patients with cisplatin-induced ototoxicity. Pharmacogenet Genomics (2017) 0.75

Treatment-related ototoxicity. J Clin Oncol (1990) 0.75

Impact of radiation technique, radiation fraction dose, and total cisplatin dose on hearing : Retrospective analysis of 29 medulloblastoma patients. Strahlenther Onkol (2017) 0.75

Articles by these authors

Impact of Event Scale: a measure of subjective stress. Psychosom Med (1979) 21.82

Novel mechanism for RNA maturation: the leader sequences of simian virus 40 mRNA are not transcribed adjacent to the coding sequences. Proc Natl Acad Sci U S A (1977) 4.64

Prevalence of gastrointestinal symptoms associated with diabetes mellitus: a population-based survey of 15,000 adults. Arch Intern Med (2001) 3.68

High incidence of secondary brain tumours after radiotherapy and antimetabolites. Lancet (1999) 3.63

Gaucher's disease variant characterised by progressive calcification of heart valves and unique genotype. Lancet (1995) 3.35

The effect of adjuvant chemotherapy on relapse-free survival in patients with osteosarcoma of the extremity. N Engl J Med (1986) 3.27

Clinical relevance of tumor cell ploidy and N-myc gene amplification in childhood neuroblastoma: a Pediatric Oncology Group study. J Clin Oncol (1991) 3.16

Crystalline Serotonin. Science (1948) 2.96

Unrelated hematopoietic stem cell donors as research subjects. Bone Marrow Transplant (2010) 2.87

Gastric emptying in normal subjects--a reproducible technique using a single scintillation camera and computer system. Gut (1983) 2.83

Safety and efficacy of a soluble P75 tumor necrosis factor receptor (Enbrel, etanercept) in patients with advanced heart failure. Circulation (1999) 2.68

Relationships of upper gastrointestinal motor and sensory function with glycemic control. Diabetes Care (2001) 2.60

Radiation response of the central nervous system. Int J Radiat Oncol Biol Phys (1995) 2.50

Chemotactic peptide modulation of actin assembly and locomotion in neutrophils. J Cell Biol (1984) 2.38

Adjuvant therapy of stage III and IV malignant melanoma using granulocyte-macrophage colony-stimulating factor. J Clin Oncol (2000) 2.37

HU-308: a specific agonist for CB(2), a peripheral cannabinoid receptor. Proc Natl Acad Sci U S A (1999) 2.32

Atypical teratoid/rhabdoid tumor of the central nervous system: a highly malignant tumor of infancy and childhood frequently mistaken for medulloblastoma: a Pediatric Oncology Group study. Am J Surg Pathol (1998) 2.32

Explicit intraoperative recall at a Bispectral Index of 47. Anesth Analg (2001) 2.27

Long-term results of St Jude Total Therapy Studies 11, 12, 13A, 13B, and 14 for childhood acute lymphoblastic leukemia. Leukemia (2009) 2.24

Cytogenetic features of human neuroblastomas and cell lines. Cancer Res (1981) 2.21

Myeloid neoplasia in children treated for solid tumours. Lancet (1990) 2.18

Expression of taste molecules in the upper gastrointestinal tract in humans with and without type 2 diabetes. Gut (2008) 2.13

Low-dose enzyme replacement therapy for Gaucher's disease: effects of age, sex, genotype, and clinical features on response to treatment. Am J Med (1994) 2.13

Cellular DNA content as a predictor of response to chemotherapy in infants with unresectable neuroblastoma. N Engl J Med (1984) 2.09

Oral mucositis and the clinical and economic outcomes of hematopoietic stem-cell transplantation. J Clin Oncol (2001) 2.05

Allogeneic blood stem cell transplantation: considerations for donors. Blood (1997) 2.03

Method for the earlier recognition of abnormal stature. Arch Dis Child (1983) 2.02

Survival outcome following isolated central nervous system relapse treated with additional chemotherapy and craniospinal irradiation in childhood acute lymphoblastic leukemia. Int J Radiat Oncol Biol Phys (1995) 2.01

Is primitive neuroectodermal tumor of the kidney a distinct entity? Cancer (1997) 1.99

Predictors of delayed gastric emptying in diabetes. Diabetes Care (2001) 1.98

There is no role for hyperfractionated radiotherapy in the management of children with newly diagnosed diffuse intrinsic brainstem tumors: results of a Pediatric Oncology Group phase III trial comparing conventional vs. hyperfractionated radiotherapy. Int J Radiat Oncol Biol Phys (1999) 1.96

Hyperglycaemia slows gastric emptying in type 1 (insulin-dependent) diabetes mellitus. Diabetologia (1990) 1.95

Low-grade astrocytoma: a decade of experience at St. Jude Children's Research Hospital. J Clin Oncol (1997) 1.94

Long-term results of Total Therapy studies 11, 12 and 13A for childhood acute lymphoblastic leukemia at St Jude Children's Research Hospital. Leukemia (2000) 1.94

Second malignancies after Ewing's sarcoma: radiation dose-dependency of secondary sarcomas. J Clin Oncol (1996) 1.90

Evidence for the existence of two types of cAMP binding sites in aggregating cells of Dictyostelium discoideum. Cell (1975) 1.89

Outcome of treatment for childhood cancer in black as compared with white children. The St Jude Children's Research Hospital experience, 1962 through 1992. JAMA (1995) 1.89

Antropyloroduodenal motor responses to intraduodenal lipid infusion in healthy volunteers. Am J Physiol (1988) 1.89

Circumcision: successful glanular reconstruction and survival following traumatic amputation. J Urol (1996) 1.88

Neuropsychologic functioning of survivors of childhood medulloblastoma randomized to receive conventional or reduced-dose craniospinal irradiation: a Pediatric Oncology Group study. J Clin Oncol (1998) 1.79

Physiological hyperglycemia slows gastric emptying in normal subjects and patients with insulin-dependent diabetes mellitus. Gastroenterology (1997) 1.77

Second malignancies in young children with primary brain tumors following treatment with prolonged postoperative chemotherapy and delayed irradiation: a Pediatric Oncology Group study. Ann Neurol (1998) 1.76

Natural history of diabetic gastroparesis. Diabetes Care (1999) 1.74

Subsequent malignancies in children and adolescents after treatment for Hodgkin's disease. J Clin Oncol (1995) 1.73

Common solid tumors of childhood. N Engl J Med (1991) 1.72

Development and validation of the Diabetes Bowel Symptom Questionnaire. Aliment Pharmacol Ther (2003) 1.68

Clinical manifestations of ganglioneuroma. Cancer (1989) 1.66

Radiotherapy improves the outlook for patients older than 1 year with Pediatric Oncology Group stage C neuroblastoma. J Clin Oncol (1991) 1.66

The effects of radiation on craniofacial skeletal growth: a quantitative study. Int J Pediatr Otorhinolaryngol (1998) 1.65

Vancomycin, ticarcillin, and amikacin compared with ticarcillin-clavulanate and amikacin in the empirical treatment of febrile, neutropenic children with cancer. N Engl J Med (1988) 1.65

Expression of chimeric genes in the early region of SV40. J Mol Appl Genet (1983) 1.65

Risks of young age for selected neurocognitive deficits in medulloblastoma are associated with white matter loss. J Clin Oncol (2001) 1.64

Hypothalamic obesity caused by cranial insult in children: altered glucose and insulin dynamics and reversal by a somatostatin agonist. J Pediatr (1999) 1.63

Donor leukocyte infusions in acute lymphocytic leukemia. Bone Marrow Transplant (2000) 1.62

Tumor size as a predictor of outcome in pediatric non-metastatic osteosarcoma of the extremity. Pediatr Blood Cancer (2004) 1.61

Association of insulin-like growth factor 1 receptor with EHD1 and SNAP29. J Biol Chem (2001) 1.61

Early intensification of intrathecal chemotherapy virtually eliminates central nervous system relapse in children with acute lymphoblastic leukemia. Blood (1998) 1.60

A specific chromosomal abnormality in rhabdomyosarcoma. Cytogenet Cell Genet (1987) 1.60

Neurocognitive deficits in medulloblastoma survivors and white matter loss. Ann Neurol (1999) 1.59

Evidence that nitric oxide mechanisms regulate small intestinal motility in humans. Gut (1999) 1.59

Gastric and esophageal emptying in dystrophia myotonica. Effect of metoclopramide. Gastroenterology (1987) 1.57

The initiation of transcription of SV40 DNA at late time after infection. Virology (1979) 1.56

Adjuvant chemotherapy of high-grade osteosarcoma of the extremity. Updated results of the Multi-Institutional Osteosarcoma Study. Clin Orthop Relat Res (1991) 1.56

Characterization of two different Ly-1+ T cell populations that mediate delayed-type hypersensitivity. J Immunol (1984) 1.55

Effects of erythromycin on gastric emptying, alcohol absorption and small intestinal transit in normal subjects. J Nucl Med (1993) 1.53

Secondary brain tumors in children treated for acute lymphoblastic leukemia at St Jude Children's Research Hospital. J Clin Oncol (1998) 1.52

The prognostic significance of autologous bone marrow transplant in advanced neuroblastoma. J Clin Oncol (1991) 1.52

A census of copies of the first edition of Andreas Vesalius' De humani corporis fabrica (1543), with a note on the recently discovered variant issue. J Hist Med Allied Sci (1984) 1.52

Local tumor control in rhabdomyosarcoma following low-dose irradiation: comparison of group II and select group III patients. Int J Radiat Oncol Biol Phys (1995) 1.51

Phase II investigational window using carboplatin, iproplatin, ifosfamide, and epirubicin in children with untreated disseminated neuroblastoma: a Pediatric Oncology Group study. J Clin Oncol (1994) 1.51

The association between Helicobacter pylori infection and functional dyspepsia in patients with irritable bowel syndrome. Am J Gastroenterol (2000) 1.50

Relationship of the motor activity of the antrum, pylorus, and duodenum to gastric emptying of a solid-liquid mixed meal. Gastroenterology (1988) 1.50

Electron microscopic evidence for splicing of SV40 late mRNAs. Cell (1978) 1.50

Disorders of gastric emptying in humans and the use of radionuclide techniques. Arch Intern Med (1985) 1.49

Osteosarcoma: good news despite crude tools. J Clin Oncol (1992) 1.49

Use of technetium-99m(V)thiocyanate to measure gastric emptying of fat. J Nucl Med (1991) 1.49

Hematologic abnormalities and acute myeloid leukemia in children and adolescents administered intensified chemotherapy for the Ewing sarcoma family of tumors. J Pediatr Hematol Oncol (2000) 1.49

Transfusion to blood group A and O patients of group B RBCs that have been enzymatically converted to group O. Transfusion (2000) 1.49

Characterization of mutations in Gaucher patients by cDNA cloning. Am J Hum Genet (1989) 1.48

A randomized placebo-controlled phase III study of granulocyte-macrophage colony-stimulating factor in adult patients (> 55 to 70 years of age) with acute myelogenous leukemia: a study of the Eastern Cooperative Oncology Group (E1490). Blood (1995) 1.47

Impact of chronic gastrointestinal symptoms in diabetes mellitus on health-related quality of life. Am J Gastroenterol (2001) 1.47

Bolus i.v. nitroglycerin treatment of ischemic chest pain in the ED. Am J Emerg Med (1994) 1.46

Stimulation of pyloric motility by intraduodenal dextrose in normal subjects. Gut (1988) 1.44

Low-stage medulloblastoma: final analysis of trial comparing standard-dose with reduced-dose neuraxis irradiation. J Clin Oncol (2000) 1.44

Biochemical variables in pre- and postmenopausal women: reconciling the calcium and estrogen hypotheses. Osteoporos Int (1999) 1.43

Relation between food intake and visual analogue scale ratings of appetite and other sensations in healthy older and young subjects. Eur J Clin Nutr (2004) 1.42

Survival and neurodevelopmental outcome of young children with medulloblastoma at St Jude Children's Research Hospital. J Clin Oncol (1999) 1.42

Osteoporosis and calcium. Aust N Z J Med (1991) 1.41

Direct translation of a protracted irinotecan schedule from a xenograft model to a phase I trial in children. J Clin Oncol (1999) 1.41

Electrophoretic distribution of serum proteins of normal and an arthritic white-tailed deer (Odocoileus virginianus). Am J Vet Res (1969) 1.41

The effects of drinks made from simple sugars on blood pressure in healthy older people. Br J Nutr (2005) 1.41

Promoter and enhancer elements in the rearranged alpha chain gene of the human T cell receptor. EMBO J (1987) 1.40

The treatment of malignant brain tumors in infants and very young children: an update of the Pediatric Oncology Group experience. Neuro Oncol (1999) 1.40

Metastatic small cell tumor of bone with 'true' rosettes and glial fibrillary acidic protein positivity. Am J Clin Pathol (1991) 1.39

Acute and chronic effects of domperidone on gastric emptying in diabetic autonomic neuropathy. Dig Dis Sci (1985) 1.39